AU2017902160A0 - New Therapeutic Treatment Combination - Google Patents

New Therapeutic Treatment Combination

Info

Publication number
AU2017902160A0
AU2017902160A0 AU2017902160A AU2017902160A AU2017902160A0 AU 2017902160 A0 AU2017902160 A0 AU 2017902160A0 AU 2017902160 A AU2017902160 A AU 2017902160A AU 2017902160 A AU2017902160 A AU 2017902160A AU 2017902160 A0 AU2017902160 A0 AU 2017902160A0
Authority
AU
Australia
Prior art keywords
therapeutic treatment
new therapeutic
treatment combination
combination
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017902160A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Go Medical Ind Pty Ltd
Original Assignee
Go Medical Ind Pty Ltd
Filing date
Publication date
Application filed by Go Medical Ind Pty Ltd filed Critical Go Medical Ind Pty Ltd
Publication of AU2017902160A0 publication Critical patent/AU2017902160A0/en
Abandoned legal-status Critical Current

Links

AU2017902160A 2017-06-06 New Therapeutic Treatment Combination Abandoned AU2017902160A0 (en)

Publications (1)

Publication Number Publication Date
AU2017902160A0 true AU2017902160A0 (en) 2017-06-22

Family

ID=

Similar Documents

Publication Publication Date Title
EP3399972A4 (en) Low dose therapeutic treatment
EP3463464A4 (en) Combination therapy
EP3732195A4 (en) Cytotoxicity-inducing therapeutic agent
EP3349751A4 (en) Cenicriviroc combination therapy for the treatment of fibrosis
EP3601536A4 (en) Treatment methods
EP3191100A4 (en) Cenicriviroc combination therapy for the treatment of fibrosis
EP3768258A4 (en) Combination therapy
EP3307240A4 (en) Combination therapy for the treatment of cancer
EP3619238A4 (en) Cytotoxicity-inducing therapeutic agent
EP3359192A4 (en) Combination therapy for the treatment of cancer
EP3258965A4 (en) Combination therapy for cancer treatment
EP3515414A4 (en) Combination therapy
EP3668507A4 (en) Combination therapy
EP3188721A4 (en) Human therapeutic agents
EP3630118A4 (en) Combination therapy
EP3609520A4 (en) Targeted combination therapy
EP3893874A4 (en) Crenolanib combination therapy
EP3419959A4 (en) Combination therapy
EP3612522A4 (en) Therapeutic compounds
EP3448263A4 (en) Electrotherapeutic treatment
EP3615502A4 (en) Therapeutic compounds and methods
EP3576791A4 (en) Calreticulin-mediated cancer treatment
GB201707500D0 (en) New therapy
GB201700526D0 (en) Therapeutic use
EP3873528A4 (en) Rasopathy treatment